[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:nfe2l2-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"NFE2L2 Gene",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07249372","DRP-104 in Patients With NFE2L2\u002FKEAP1-altered Non-Small Cell Lung Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:16:24.970704Z","2026-05-05T02:43:29.674125Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05039801","IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors",[19],"Phase 1","2026-08-26T02:18:49.989941Z","2026-04-29T02:57:57.070174Z"]